MedPath
HSA Approval

Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation

SIN17100P

Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation

Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation

September 25, 2024

ORIENT EUROPHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantORIENT EUROPHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

AEROSOL, METERED

RESPIRATORY (INHALATION)

Medical Information

R03AK08

Manufacturer Information

ORIENT EUROPHARMA PTE LTD

Chiesi Farmaceutici S.p.A.

Active Ingredients

Beclometasone dipropionate

0.200mg/actuation

Formoterol fumarate dihydrate

0.006mg/actuation

Aluminum sulfate

Documents

Package Inserts

FOSTER solution PI.pdf

Approved: September 25, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation - HSA Approval | MedPath